Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock a double-blind, randomized, placebo-controlled trial
CC BY
Saved in:
Main Authors: | Thomas, Daix, Armelle, Mathonnet, Scott, Brakenridge |
---|---|
Format: | Book |
Language: | English |
Published: |
Springer
2023
|
Subjects: | |
Online Access: | https://link.springer.com/article/10.1186/s13613-023-01109-w https://dlib.phenikaa-uni.edu.vn/handle/PNK/6913 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
by: Marius, Trøseid, et al.
Published: (2023) -
Elevated free interleukin-18 associated with severity and mortality in prospective cohort study of 206 hospitalised COVID-19 patients
by: Syed M. T., Nasser, et al.
Published: (2023) -
(NH4)2[Co(H2O)6]2V10O28·4H2O Vs. (NH4)2[Ni(H2O)6]2V10O28·4H2O: Structural, Spectral and Thermal Analyses and Evaluation of Their Antibacterial Activities
by: Ayat-Allah, Mamdouh, et al.
Published: (2023) -
Descriptive statistics and risk factor analysis of children with community-acquired septic shock
by: Shinya, Miura, et al.
Published: (2023) -
Giao diện người và máy (HMI) với S7 và Intouch /
by: Lê, Ngọc Bích
Published: (2013)